Following a limited submission
AWMSG advice |
||||
| Status: Recommended | ||||
Trifarotene (Aklief®▼) is recommended as an option for use within NHS Wales for the cutaneous treatment of Acne Vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present. |
||||
|
||||
Medicine details |
||||
| Medicine name | trifarotene (Aklief®) | |||
| Formulation | 50 microgram/g cream | |||
| Reference number | 3153 | |||
| Indication | For the cutaneous treatment of Acne Vulgaris of the face and/ or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present |
|||
| Company | Galderma (UK) Ltd | |||
| BNF chapter | Skin | |||
| Submission type | Limited | |||
| Status | Recommended | |||
| Advice number | 0124 | |||
| NMG meeting date | 28/02/2024 | |||
| AWMSG meeting date | 17/04/2024 | |||
| Date of issue | 29/04/2024 | |||